Wednesday, August 5, 2009

Cancer vaccine testing readied for Pitt development

Some people appear to be immune to overproducing a protein associated with many cancers, giving doctors hope that they hold the key to developing a vaccine against breast, lung, and head and neck cancers.

And when University of Pittsburgh School of Medicine scientists tested such a vaccine in mice, it allowed them to fight off exposure to cancerous cells, according to a report published late Monday in the Proceedings of the National Academy of Sciences.

Read more: http://www.pittsburghlive.com/x/pittsburghtrib/news/pittsburgh/s_636633.html

No comments:

Post a Comment